Clinical study of the Ginko biloba--Troxerutin-Heptaminol Hce in the treatment of acute hemorrhoidal attacks.

Panuwat Lertsithichai, Kanit Sumboonnanonda

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2004;87(2):137-42

PMID: 15061296

Abstract

OBJECTIVE

The aim of this study was to assess the clinical efficacy, compliance and safety of Ginko biloba--Troxerutin-Heptaminol Hce in the treatment of patients with acute hemorrhoidal attacks in Thailand.

MATERIAL AND METHOD

In a prospective clinical study on hospital outpatients, the authors studied the effect of Ginko biloba--Troxerutin-Heptaminol Hce for a week in adults (18-70 years old) with acute hemorrhoidal attacks.

RESULT

Twenty-two patients, with a mean age of 41.7 years were included in the study. The male to female ratio was 1 : 1.2. Most patients (77%) had grade 1 and 2 hemorrhoids with an average duration of attacks of 3 days. On intention to treat analysis, bleeding, pain, tenesmus and discharge were significantly improved. Treatment was well accepted and safe.

CONCLUSION

In the short-term, Ginko biloba--Troxerutin-Heptaminol Hce is effective, acceptable and safe in the treatment of patients with acute hemorrhoidal attacks.

Address: Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.

Link outs

Free resources

Medical:

https://medlineplus.gov/hemorrhoids.html

MeSH Terms: Acute Disease, Adolescent, Adult, Aged, Drug Therapy, Combination, Female, Follow-Up Studies, Ginkgo biloba, Hemorrhoids, Heptaminol, Humans, Hydroxyethylrutoside, Male, Middle Aged, Pain Measurement, Phytotherapy, Prospective Studies, Risk Assessment, Severity of Illness Index, Treatment Outcome